Thanh bên bài viết
Ngày xuất bản:
24/04/2024
Ngày xuất bản Online:
28/02/2024
Số lượt xem tóm tắt: 13
Số xuất bản
Chuyên mục
Bài báo
Trích dẫn bài báo
Nguyễn, N. T. (2024). Chất thay thế da và liệu pháp chữa liền vết thương dựa trên tế bào (Tổng quan). Tạp chí Y học Thảm hoạ và Bỏng, 1, 53-62. https://doi.org/10.54804/yhthvb.1.2024.283
Chất thay thế da và liệu pháp chữa liền vết thương dựa trên tế bào (Tổng quan)
Nội dung chính của bài viết
Tóm tắt
Có rất nhiều loại vật liệu thay thế da phân nhóm theo đặc tính sinh học, nhưng tác dụng chính là cải thiện môi trường cho liền vết thương (LVT). Chúng không các tác dụng kháng khuẩn nhưng khi vết thương được che phủ kín thì nguy cơ nhiễm khuẩn giảm đi rất nhiều. Tác dụng chính của các vật liệu sinh học bao gồm: che phủ và bảo vệ vết thương; giảm đau; phục hồi được môi trường sinh học tốt nhất cho bề mặt vết thuơng, kích thích quá trình liền vết thương; cải thiện chất lượng sẹo da sau khi vết thương liền; góp phần giảm tỷ lệ tử vong và tăng cường chất lượng cuộc sống của bệnh nhân sau khi khỏi bỏng.
Chi tiết bài viết
Tài liệu tham khảo
1. Melanie Rodrigues, Nina Kosaric, Clark A. Bonham, and Geoffrey C. Gurtner; wound healing: a cellular perspective; Physiol Rev 99: 665–706, 2019;
2. Castagnoli C, Stella M, Magliacani G, Alasia ST, Richiardi P. Anomalous expression of HLA class II molecules on keratinocytes and fibroblasts in hypertrophic scars consequent to thermal injury. Clin Exp Immunol 82: 350–354, 1990.
3. Sedmak DD, Orosz CG. The role of vascular endothelial cells in transplantation. Arch Pathol Lab Med 115: 260–265, 1991.
4. Yukna RA, Turner DW, Robinson LJ. Variable antigenicity of lyophilized allogeneic and lyophilized xenogeneic skin in guinea pigs. J Periodontal Res 12: 197–203, 1977. .
5. Sun G, Zhang X, Shen YI, Sebastian R, Dickinson LE, Fox-Talbot K, Reinblatt M, Steenbergen C, Harmon JW, Gerecht S. Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing. Proc Natl Acad Sci USA 108: 20976–20981, 2011.
6. Frame JD, Still J, Lakhel-LeCoadou A, Carstens MH, Lorenz C, Orlet H, Spence R, Berger AC, Dantzer E, Burd A. Use of dermal regeneration template in contracture release procedures: a multicenter evaluation. Plast Reconstr Surg 113: 1330–1338, 2004.
7. Huss FR, Nyman E, Gustafson CJ, Gisselfält K, Liljensten E, Kratz G. Characterization of a new degradable polymer scaffold for regeneration of the dermis: in vitro and in vivo human studies. Organogenesis 4: 195–200, 2008.
8. Dantzer E, Braye FM. Reconstructive surgery using an artificial dermis (Integra): results with 39 grafts. Br J Plast Surg 54: 659–664, 2001.
9. Truong AT, Kowal-Vern A, Latenser BA, Wiley DE, Walter RJ. Comparison of dermal substitutes in wound healing utilizing a nude mouse model. J Burns Wounds 4: e4, 2005.
10. Koob TJ, Lim JJ, Massee M, Zabek N, Denozière G. Properties of dehydrated human amnion/chorion composite grafts: Implications for wound repair and soft tissue regeneration. J Biomed Mater Res B Appl Biomater 102: 1353–1362, 2014.
11. Koob TJ, Lim JJ, Massee M, Zabek N, Rennert R, Gurtner G, Li WW. Angiogenic properties of dehydrated human amnion/chorion allografts: therapeutic potential for soft tissue repair and regeneration. Vasc Cell 6: 10, 2014.
12. Forbes J, Fetterolf DE. Dehydrated amniotic membrane allografts for the treatment of chronic wounds: a case series. J Wound Care 21: 290–296, 2012.
13. Mostow EN, Haraway GD, Dalsing M, Hodde JP, King D; OASIS Venus Ulcer Study Group. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg 41: 837–843, 2005.
14. Romanelli M, Dini V, Bertone M, Barbanera S, Brilli C. OASIS wound matrix versus Hyaloskin in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology. Int Wound J 4: 3–7, 2007.
15. Niezgoda JA, Van Gils CC, Frykberg RG, Hodde JP. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Adv Skin Wound Care 18: 258–266, 2005.
16. Shores JT, Gabriel A, Gupta S. Skin substitutes and alternatives: a review. Adv Skin Wound Care 20: 493–508, 2007.
17. Wainwright DJ. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns 21: 243–248, 1995.
18. Carsin H, Ainaud P, Le Bever H, Rives J, Lakhel A, Stephanazzi J, Lambert F, Perrot J.Cultured epithelial autografts in extensive burn coverage of severely traumatizedpatients: a five year single-center experience with 30 patients. Burns 26: 379–387,2000.
19. Williamson JS, Snelling CF, Clugston P, Macdonald IB, Germann E. Cultured epithelial autograft: five years of clinical experience with twenty-eight patients. J Trauma 39:309–319, 1995.
20. Varkey M, Ding J, Tredget EE. Advances in Skin Substitutes-Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing. J Funct Biomater 6: 547–563, 2015.
21. Gordley K, Cole P, Hicks J, Hollier L. A comparative, long term assessment of soft tissue substitutes: AlloDerm, Enduragen, and Dermamatrix. J Plast Reconstr Aesthet Surg 62: 849–850, 2009.
22. Hart CE, Loewen-Rodriguez A, Lessem J. Dermagraft: Use in the Treatment of Chronic Wounds. Adv Wound Care (New Rochelle) 1: 138–141, 2012.
23. Gibbons GW. Grafix®, a Cryopreserved Placental Membrane, for the Treatment of Chronic/Stalled Wounds. Adv Wound Care (New Rochelle) 4: 534–544, 2015.
24. Lavery LA, Fulmer J, Shebetka KA, Regulski M, Vayser D, Fried D, Kashefsky H, Owings TM, Nadarajah J; Grafix Diabetic Foot Ulcer Study Group. The efficacy and safety of Grafix(®) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial. Int Wound J 11: 554–560, 2014. .
25. Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, DiPietro L, Falanga V, Fife C, Gardner S, Grice E, Harmon J, Hazzard WR, High KP, Houghton P, Jacobson N, Kirsner RS, Kovacs EJ, Margolis D, McFarland Horne F, Reed MJ, Sullivan DH,Thom S, Tomic-Canic M, Walston J, Whitney J, Williams J, Zieman S, Schmader K. Chronic wound repair and healing in older adults: current status and future research. Wound Repair Regen 23: 1–13, 2015.
26. McGranahan N, Swanton C. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell 168: 613–628, 2017.
27. . Wu H, Wang C, Wu Z. PROPER: comprehensive power evaluation for differential expression using RNA-seq. Bioinformatics 31: 233–241, 2015.
28. Ziegenhain C, Vieth B, Parekh S, Reinius B, Guillaumet-Adkins A, Smets M, Leonhardt H, Heyn H, Hellmann I, Enard W. Comparative analysis of single-cell RNA-sequencing methods. Mol Cell 65: 631–643.e4, 2017.
29. Januszyk M, Gurtner GC. High-Throughput Single-Cell Analysis for Wound Healing Applications. Adv Wound Care (New Rochelle) 2: 457–469, 2013.
30. Gierahn TM, Wadsworth MH II, Hughes TK, Bryson BD, Butler A, Satija R, Fortune S, Love JC, Shalek AK. Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput. Nat Methods 14: 395–398, 2017.
31. Rennert RC, Januszyk M, Sorkin M, Rodrigues M, Maan ZN, Duscher D, Whittam AJ, Kosaraju R, Chung MT, Paik K, Li AY, Findlay M, Glotzbach JP, Butte AJ, Gurtner GC.Microfluidic single-cell transcriptional analysis rationally identifies novel surface marker profiles to enhance cell-based therapies. Nat Commun 7: 11945, 2016.
32. Rinkevich Y, Walmsley GG, Hu MS, Maan ZN, Newman AM, Drukker M, Januszyk M, Krampitz GW, Gurtner GC, Lorenz HP, Weissman IL, Longaker MT. Skin fibrosis.Identification and isolation of a dermal lineage with intrinsic fibrogenic potential. Science 348: aaa2151, 2015.
33. Faraz Chogan, Yufei Chen, Fiona Wood and Marc G. Jeschke (2023), Skin Tissue Engineering Advances in Burns: A Brief Introduction to the Past, the Present, and the Future Potential; Journal of Burn Care & Research; January/February 2023; supplement article, S1- S4
34. Paula Pleguezuelos-Beltrán, Patricia Gálvez-Martín, Daniel Nieto-García, Juan Antonio Marchal, Elena López-Ruiz; Advances in spray products for skin regenerationBioactive Materials; Volume 16, October 2022, Pages 187-203
2. Castagnoli C, Stella M, Magliacani G, Alasia ST, Richiardi P. Anomalous expression of HLA class II molecules on keratinocytes and fibroblasts in hypertrophic scars consequent to thermal injury. Clin Exp Immunol 82: 350–354, 1990.
3. Sedmak DD, Orosz CG. The role of vascular endothelial cells in transplantation. Arch Pathol Lab Med 115: 260–265, 1991.
4. Yukna RA, Turner DW, Robinson LJ. Variable antigenicity of lyophilized allogeneic and lyophilized xenogeneic skin in guinea pigs. J Periodontal Res 12: 197–203, 1977. .
5. Sun G, Zhang X, Shen YI, Sebastian R, Dickinson LE, Fox-Talbot K, Reinblatt M, Steenbergen C, Harmon JW, Gerecht S. Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing. Proc Natl Acad Sci USA 108: 20976–20981, 2011.
6. Frame JD, Still J, Lakhel-LeCoadou A, Carstens MH, Lorenz C, Orlet H, Spence R, Berger AC, Dantzer E, Burd A. Use of dermal regeneration template in contracture release procedures: a multicenter evaluation. Plast Reconstr Surg 113: 1330–1338, 2004.
7. Huss FR, Nyman E, Gustafson CJ, Gisselfält K, Liljensten E, Kratz G. Characterization of a new degradable polymer scaffold for regeneration of the dermis: in vitro and in vivo human studies. Organogenesis 4: 195–200, 2008.
8. Dantzer E, Braye FM. Reconstructive surgery using an artificial dermis (Integra): results with 39 grafts. Br J Plast Surg 54: 659–664, 2001.
9. Truong AT, Kowal-Vern A, Latenser BA, Wiley DE, Walter RJ. Comparison of dermal substitutes in wound healing utilizing a nude mouse model. J Burns Wounds 4: e4, 2005.
10. Koob TJ, Lim JJ, Massee M, Zabek N, Denozière G. Properties of dehydrated human amnion/chorion composite grafts: Implications for wound repair and soft tissue regeneration. J Biomed Mater Res B Appl Biomater 102: 1353–1362, 2014.
11. Koob TJ, Lim JJ, Massee M, Zabek N, Rennert R, Gurtner G, Li WW. Angiogenic properties of dehydrated human amnion/chorion allografts: therapeutic potential for soft tissue repair and regeneration. Vasc Cell 6: 10, 2014.
12. Forbes J, Fetterolf DE. Dehydrated amniotic membrane allografts for the treatment of chronic wounds: a case series. J Wound Care 21: 290–296, 2012.
13. Mostow EN, Haraway GD, Dalsing M, Hodde JP, King D; OASIS Venus Ulcer Study Group. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg 41: 837–843, 2005.
14. Romanelli M, Dini V, Bertone M, Barbanera S, Brilli C. OASIS wound matrix versus Hyaloskin in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology. Int Wound J 4: 3–7, 2007.
15. Niezgoda JA, Van Gils CC, Frykberg RG, Hodde JP. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Adv Skin Wound Care 18: 258–266, 2005.
16. Shores JT, Gabriel A, Gupta S. Skin substitutes and alternatives: a review. Adv Skin Wound Care 20: 493–508, 2007.
17. Wainwright DJ. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns 21: 243–248, 1995.
18. Carsin H, Ainaud P, Le Bever H, Rives J, Lakhel A, Stephanazzi J, Lambert F, Perrot J.Cultured epithelial autografts in extensive burn coverage of severely traumatizedpatients: a five year single-center experience with 30 patients. Burns 26: 379–387,2000.
19. Williamson JS, Snelling CF, Clugston P, Macdonald IB, Germann E. Cultured epithelial autograft: five years of clinical experience with twenty-eight patients. J Trauma 39:309–319, 1995.
20. Varkey M, Ding J, Tredget EE. Advances in Skin Substitutes-Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing. J Funct Biomater 6: 547–563, 2015.
21. Gordley K, Cole P, Hicks J, Hollier L. A comparative, long term assessment of soft tissue substitutes: AlloDerm, Enduragen, and Dermamatrix. J Plast Reconstr Aesthet Surg 62: 849–850, 2009.
22. Hart CE, Loewen-Rodriguez A, Lessem J. Dermagraft: Use in the Treatment of Chronic Wounds. Adv Wound Care (New Rochelle) 1: 138–141, 2012.
23. Gibbons GW. Grafix®, a Cryopreserved Placental Membrane, for the Treatment of Chronic/Stalled Wounds. Adv Wound Care (New Rochelle) 4: 534–544, 2015.
24. Lavery LA, Fulmer J, Shebetka KA, Regulski M, Vayser D, Fried D, Kashefsky H, Owings TM, Nadarajah J; Grafix Diabetic Foot Ulcer Study Group. The efficacy and safety of Grafix(®) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial. Int Wound J 11: 554–560, 2014. .
25. Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, DiPietro L, Falanga V, Fife C, Gardner S, Grice E, Harmon J, Hazzard WR, High KP, Houghton P, Jacobson N, Kirsner RS, Kovacs EJ, Margolis D, McFarland Horne F, Reed MJ, Sullivan DH,Thom S, Tomic-Canic M, Walston J, Whitney J, Williams J, Zieman S, Schmader K. Chronic wound repair and healing in older adults: current status and future research. Wound Repair Regen 23: 1–13, 2015.
26. McGranahan N, Swanton C. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell 168: 613–628, 2017.
27. . Wu H, Wang C, Wu Z. PROPER: comprehensive power evaluation for differential expression using RNA-seq. Bioinformatics 31: 233–241, 2015.
28. Ziegenhain C, Vieth B, Parekh S, Reinius B, Guillaumet-Adkins A, Smets M, Leonhardt H, Heyn H, Hellmann I, Enard W. Comparative analysis of single-cell RNA-sequencing methods. Mol Cell 65: 631–643.e4, 2017.
29. Januszyk M, Gurtner GC. High-Throughput Single-Cell Analysis for Wound Healing Applications. Adv Wound Care (New Rochelle) 2: 457–469, 2013.
30. Gierahn TM, Wadsworth MH II, Hughes TK, Bryson BD, Butler A, Satija R, Fortune S, Love JC, Shalek AK. Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput. Nat Methods 14: 395–398, 2017.
31. Rennert RC, Januszyk M, Sorkin M, Rodrigues M, Maan ZN, Duscher D, Whittam AJ, Kosaraju R, Chung MT, Paik K, Li AY, Findlay M, Glotzbach JP, Butte AJ, Gurtner GC.Microfluidic single-cell transcriptional analysis rationally identifies novel surface marker profiles to enhance cell-based therapies. Nat Commun 7: 11945, 2016.
32. Rinkevich Y, Walmsley GG, Hu MS, Maan ZN, Newman AM, Drukker M, Januszyk M, Krampitz GW, Gurtner GC, Lorenz HP, Weissman IL, Longaker MT. Skin fibrosis.Identification and isolation of a dermal lineage with intrinsic fibrogenic potential. Science 348: aaa2151, 2015.
33. Faraz Chogan, Yufei Chen, Fiona Wood and Marc G. Jeschke (2023), Skin Tissue Engineering Advances in Burns: A Brief Introduction to the Past, the Present, and the Future Potential; Journal of Burn Care & Research; January/February 2023; supplement article, S1- S4
34. Paula Pleguezuelos-Beltrán, Patricia Gálvez-Martín, Daniel Nieto-García, Juan Antonio Marchal, Elena López-Ruiz; Advances in spray products for skin regenerationBioactive Materials; Volume 16, October 2022, Pages 187-203